PEAK6 Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PEAK6 Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$47.8M	Buy	502,500 +49,900	+11%	+$4.59M	0.2%	74
2018 Q1	$39.7M	Buy	452,600 +118,200	+35%	+$10.8M	0.17%	82
2017 Q4	$28.4M	Buy	334,400 +64,600	+24%	+$5.41M	0.13%	158
2017 Q3	$23.4M	Buy	269,800 +10,000	+4%	+$802K	0.12%	174
2017 Q2	$20.1M	Buy	259,800 +45,300	+21%	+$3.21M	0.12%	157
2017 Q1	$14.9M	Buy	214,500 +212,600	+11,189%	+$14.3M	0.12%	182
2016 Q4	$112K	Buy	1,900 +1,800	+1,800%	+$111K	﹤0.01%	3794
2016 Q3	$7K	Sell	100 -1,400	-93%	-$86.6K	﹤0.01%	4197
2016 Q2	$81K	Sell	1,500 -3,600	-71%	-$197K	﹤0.01%	3679
2016 Q1	$263K	Sell	5,100 -60,400	-92%	-$3.14M	﹤0.01%	2875
2015 Q4	$4.6M	Sell	65,500 -178,500	-73%	-$12.2M	0.03%	780
2015 Q3	$15.2M	Buy	244,000 +214,000	+713%	+$16.9M	0.08%	301
2015 Q2	$2.52M	Sell	30,000 -161,700	-84%	-$12.6M	0.02%	1297
2015 Q1	$14.4M	Buy	+191,700	New	+$13.4M	0.11%	198

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

PEAK6 Group's XBI Position: Q2 2018 in Review

PEAK6 Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 13,033 shares — an estimated $1.2M sold.

PEAK6 Group first reported a position in XBI in Q1 2016 and held it in 5 quarters. The position peaked at $3.06M in Q4 2017. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

PEAK6 Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 13,033 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $1.2M.
PEAK6 Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and held it in 5 quarters.
PEAK6 Group's State Street SPDR S&P Biotech ETF position peaked at $3.06M in Q4 2017.
431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.